系统性红斑狼疮中外泌体及其作用的研究进展
Advances in Studies on Exosomes and Their Roles in Systemic Lupus Erythematosus
DOI: 10.12677/ACM.2022.12121725, PDF,   
作者: 吕 攀, 刘平丹, 周晓琴, 朱茂灵, 刘剑平*:川北医学院附属医院,四川 南充
关键词: 系统性红斑狼疮外泌体Systemic Lupus Erythematosus (SLE) Exosome
摘要: 外泌体(exosomes)是携带多种蛋白质、脂质和遗传物质的细胞外囊泡,参与局部和系统间信息的交换,在多种自身免疫性疾病中发挥重要的免疫调节作用。外泌体具有稳定性、低免疫原性、生物相容性和克服生物屏障等固有特性,使其可以成为药物载体,特别是用于基因治疗。本文将综述外泌体在SLE中的作用,有助于为研究SLE的病因机制和SLE治疗的靶向提供新的方向。
Abstract: Exosomes are extracellular vesicles that carry a variety of proteins, genetic material and lipids, they are involved in the exchange of local and intersystemic information, and play an important immunomodulatory role in a variety of autoimmune diseases. Exosomes have inherent properties such as stability, low immunogenicity, biocompatibility, and overcoming biological barriers, and has potential for drug vectors, especially for gene therapy. This paper will review the role of exosomes in SLE, which will help to provide a new direction for the study of the etiological mechanism of SLE and the targeting of SLE therapy.
文章引用:吕攀, 刘平丹, 周晓琴, 朱茂灵, 刘剑平. 系统性红斑狼疮中外泌体及其作用的研究进展[J]. 临床医学进展, 2022, 12(12): 11975-11979. https://doi.org/10.12677/ACM.2022.12121725

参考文献

[1] Dong, G., Yang, Y., Li, X., Yao, X., Zhu, Y., Zhang, H., Wang, H., Ma, Q., Zhang, J., Shi, H., Ning, Z., Yan, F., Zhai, W., Dai, J., Li, Z., Li, C., Ming, J., Xue, Q., Meng, X., Si, C. and Xiong, H. (2020) Granulocytic Myeloid-Derived Suppressor Cells Contribute to IFN-I Signaling Activation of B Cells and Disease Progression through the lncRNA NEAT1-BAFF Axis in Systemiclupus Erythematosus. Biochimica et Biophysica Acta—Molecular Basis of Disease, 1866, Article ID: 165554. [Google Scholar] [CrossRef] [PubMed]
[2] Tsai, C.Y., Li, K.J., Hsieh, S.C., Liao, H.T. and Yu, C.L. (2019) What’s Wrong with Neutrophils in Lupus? Clinical and Experimental Rheumatology, 37, 684-693.
[3] Tsai, C.Y., Hsieh, S.C., Lu, C.S., Wu, T.H., Liao, H.T., Wu, C.H., Li, K.J., Kuo, Y.M., Lee, H.T., Shen, C.Y. and Yu, C.L. (2019) Cross-Talk between Mitochondrial Dysfunction Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. International Journal of Molecular Sciences, 20, Article 5183. [Google Scholar] [CrossRef] [PubMed]
[4] Kaul, A., Gordon, C., Crow, M.K., Touma, Z., Urowitz, M.B., van Vollenhoven, R., et al. (2016) Systemic Lupus Erythematosus. Nature Reviews Disease Primers, 2, Article No. 16039. [Google Scholar] [CrossRef] [PubMed]
[5] Mahieu, M.A., Strand, V., Simon, L.S., Lipsky, P.E. and Ramsey-Goldman, R. (2016) A Critical Review of Clinical Trials in Systemic Lupus Erythematosus. Lupus, 25, 1122-1140. [Google Scholar] [CrossRef] [PubMed]
[6] Mashouri, L., Yousefifi, H., Aref, A.R., Ahadi, A.M., Molaei, F. and Alahari, S.K. (2019) Exosomes: Composition, Biogenesis, and Mechanisms in Cancer Metastasis and Drug Resistance. Molecular Cancer, 18, Article No. 75. [Google Scholar] [CrossRef] [PubMed]
[7] Rayamajhi, S., Nguyen, T.D.T., Marasini, R. and Aryal, S. (2019) Macrophage-Derived Exosome-Mimetic Hybrid Vesicles for Tumor Targeted Drug Delivery. Acta Biomaterialia, 94, 482-494. [Google Scholar] [CrossRef] [PubMed]
[8] Tan, L., Wu, H., Liu, Y., Zhao, M., Li, D. and Lu, Q. (2016) Recent Advances of Exosomes in Immune Modulation and Autoimmune Diseases. Autoimmunity, 49, 357-365. [Google Scholar] [CrossRef] [PubMed]
[9] Pegtel, D.M. and Gould, S.J. (2019) Exosomes. Annual Re-view of Biochemistry, 88, 487-514. [Google Scholar] [CrossRef] [PubMed]
[10] Thery, C., Zitvogel, L. and Amigorena, S. (2002) Exosomes: Composition, Biogenesis and Function. Nature Reviews Immunology, 2, 569-579. [Google Scholar] [CrossRef] [PubMed]
[11] Cosenza, S., Toupet, K., Maumus, M., Luz-Crawford, P., Blanc-Brude, O., Jorgensen, C. and Noël, D. (2018) Mesenchymal Stem Cells-Derived Exosomes Are More Immunosuppressive than Microparticles in Inflammatory Arthritis. Theranostics, 8, 1399-1410. [Google Scholar] [CrossRef] [PubMed]
[12] Mathieu, M., Martin-Jaular, L., Lavieu, G. and Théry, C. (2019) Speci-ficities of Secretion and Uptake of Exosomes and Other Extracellular Vesicles for Cell-to-Cell Communication. Nature Cell Biology, 21, 9-17. [Google Scholar] [CrossRef] [PubMed]
[13] Nath, S., Agholme, L., Kurudenkandy, F.R., Granseth, B., Marcusson, J. and Hallbeck, M. (2012) Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid. Journal of Neuroscience, 32, 8767-8777. [Google Scholar] [CrossRef
[14] Arellano-Anaya, Z.E., Huor, A., Leblanc, P., Lehmann, S., Provansal, M., Raposo, G., et al. (2015) Prion Strains Are Differentially Released through the Exosomal Pathway. Cellular and Molecular Life Sciences, 72, 1185-1196. [Google Scholar] [CrossRef] [PubMed]
[15] Lööv, C., Scherzer, C.R., Hyman, B.T., Breakefifield, X.O. and Ingelsson, M. (2016) α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities. Cellular and Molecular Neurobiology, 36, 437-448. [Google Scholar] [CrossRef] [PubMed]
[16] 徐莹, 周茹, 张欣洲, 等. SLE患者血清外泌体环状RNA的差异表达分析[J]. 湖北科技学院学报(医学版), 2022, 36(2): 129-133, 137. [Google Scholar] [CrossRef
[17] Long, H., Wang, X., Chen, Y., Wang, L., Zhao, M. and Lu, Q. (2018) Dysregulation of microRNAs in Autoimmune Diseases: Pathogenesis, Biomarkers and Potential Therapeutic Targets. Cancer Letters, 428, 90-103. [Google Scholar] [CrossRef] [PubMed]
[18] Perez-Hernandez, J., Redon, J. and Cortes, R. (2017) Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 18, Article 717. [Google Scholar] [CrossRef] [PubMed]
[19] Perez-Hernandez, J., Martinez-Arroyo, O., Ortega, A., Galera, M., Solis-Salguero, M.A., Chaves, F.J., Redon, J., Forner, M.J. and Cortes, R. (2021) Urinary Exosomal miR-146a as a Marker of Albuminuria, Activity Changes and Disease Flares in Lupus Nephritis. Journal of Nephrology, 34, 1157-1167. [Google Scholar] [CrossRef] [PubMed]
[20] Dong, C., Zhou, Q., Fu, T., Zhao, R., Yang, J., Kong, X., Zhang, Z., Sun, C., Bao, Y., Ge, X., Zhang, Z., Lu, Z., Li, J., Zheng, W., Gu, Z. and Ji, J. (2019) Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells. BioMed Research International, 2019, Article ID: 6071308. [Google Scholar] [CrossRef] [PubMed]
[21] Li, W., Liu, S., Chen, Y., Weng, R., Zhang, K., He, X. and He, C. (2020) Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus. Clinics (Sao Paulo), 75, e1528. [Google Scholar] [CrossRef] [PubMed]
[22] Huang, Y., Li, R., Ye, S., Lin, S., Yin, G. and Xie, Q. (2020) Recent Advances in the Use of Exosomes in Sjögren’s Syndrome. Frontiers in Immunology, 11, Article 1509. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, J.Y., Li, Y.J., Hu, X.B., Huang, S. and Xiang, D.X. (2021) Preservation of Small Extracellular Vesicles for Functional Analysis and Therapeutic Applications: A Comparative Evaluation of Storage Conditions. Drug Delivery, 28, 162-170. [Google Scholar] [CrossRef] [PubMed]
[24] Yang, D., Zhang, W., Zhang, H., et al. (2020) Progress, Opportunity, and Perspective on Exosome Isolation—Efforts for efficient Exosome-Based Theranostics. Theranostics, 10, 3684-3707. [Google Scholar] [CrossRef] [PubMed]
[25] Duan, L., Xu, L., Xu, X., et al. (2021) Exosome-Mediated Delivery of Gene Vectors for Gene Therapy. Nanoscale, 13, 1387-1397. [Google Scholar] [CrossRef
[26] Peng, H., Ji, W., Zhao, R., Yang, J., Lu, Z., Li, Y. and Zhang, X. (2020) Exosome: A Significant Nanoscale Drug Delivery Carrier. Journal of Materials Chemistry B, 8, 7591-7608. [Google Scholar] [CrossRef
[27] Elliott, R.O. and He, M. (2021) Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery. Pharmaceutics, 13, Article 122. [Google Scholar] [CrossRef] [PubMed]
[28] Gutierrez-Millan, C., Calvo Díaz, C., Lanao, J.M. and Colino, C.I. (2021) Advances in Exosomes-Based Drug Delivery Systems. Macromolecular Bioscience, 21, e2000269. [Google Scholar] [CrossRef] [PubMed]
[29] Kim, H., Jang, H., Cho, H., et al. (2021) Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers, 13, Article 4435. [Google Scholar] [CrossRef] [PubMed]